EMA — authorised 22 March 2002
- Application: EMEA/H/C/000381
- Marketing authorisation holder: Pfizer Europe MA EEIG
- Local brand name: Dynastat
- Indication: For the short-term treatment of postoperative pain in adults.
- Status: approved
🇪🇺 Parecoxib and remifentanil in European Union
EMA authorised Parecoxib and remifentanil on 22 March 2002
Marketing authorisation
Other Pain Management / Anesthesia approved in European Union
Frequently asked questions
Is Parecoxib and remifentanil approved in European Union?
Yes. EMA authorised it on 22 March 2002.
Who is the marketing authorisation holder for Parecoxib and remifentanil in European Union?
Pfizer Europe MA EEIG holds the EU marketing authorisation.